Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic
- Friday, January 22, 2021, 7:01
- Finance
- Add a comment
BOSTON, Jan. 22, 2021 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE) (“Haemonetics”), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, affirms its support of new guidance issued by the U.S. Food and Drug…
About the Author
adminasapcorp has written 41806 stories on this site.